3.0
5. Jan. 2013
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
New York, NY
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Opportunity to work with some really great people. As a large company, many opportunities to develop oneself by applying for more challenging positions. Some teams are well aligned.
Kontras
Steady stream of layoffs results in general unease - who will be next? The pharmaceutical business model is changing dramatically due to lack of significant new products, regulatory pressure on sales, inability to influence managed healthcare decision makers, etc. The good old days of pharma are over. Overly bureaucratic, and can be slow to make decisions